• Explore /
  • Poster
  • / Prognostic factors in patients (pts) with advanced biliary tract cancer (BTC) treated with first-line gemcitabine plus cisplatin (GEMCIS): Retrospective analysis of 740 pts.

Prognostic factors in patients (pts) with advanced biliary tract cancer (BTC) treated with first-line gemcitabine plus cisplatin (GEMCIS): Retrospective analysis of 740 pts.

Abstract Poster

Authors

null

Hyungwoo Cho

Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Hyungwoo Cho , Bumjun Kim , Changhoon Yoo , Kyu-Pyo Kim , Jaewon Hyung , Sang Soo Lee , Do Hyun Park , Tae Jun Song , Dong Wan Seo , Sung Koo Lee , Myung-Hwan Kim , Jin-hong Park , Heung-Moon Chang , Baek-Yeol Ryoo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 424)

DOI

10.1200/JCO.2017.35.4_suppl.424

Abstract #

424

Poster Bd #

K8

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Prognostic effects of co-occurring <i>TP53</i> and <i>KRAS</i> aberrations in patients with advanced biliary tract cancer.

Prognostic effects of co-occurring TP53 and KRAS aberrations in patients with advanced biliary tract cancer.

First Author: Taro Shibuki

First Author: Mohamed Bouattour

First Author: Jia Fan

First Author: YunJung Kim